First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer
Clinical trial NCT03804580 · UNKNOWN
Trial details
- NCT number
- NCT03804580
- Sponsor
- Vestre Viken Hospital Trust
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2025-06-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.